EasyPGX ready: a complete portfolio for rapid diagnosis and prognosis
EasyPGX Ready is the best-in-class RT-PCR diagnostic solution for oncohematology with a fast and simple workflow based on dry and ready-to-use reagent format.
One step Real-Time PCR
Validated for RNA extracted from whole blood, bone marrow and buffy coat
TAT from RNA to result < 80 min
Hands on Time < 10 min
Same thermal profile for all different RNA kits
Qualitative detection and discrimination of principal fusion variants in one single run
EasyPGX Real-Time PCR System
RT-PCR instrument with 96 wells peltier block
Up to 6 LED optical channels • Integrated touch screen
Automatic data analysis and interpretation software
System complete of all accessory instrumentation needed for EasyPGX ready workflow
EasyPGX Analysis Software: automatic data analysis solution
EasyPGX Analysis Software is the automatic data analysis software dedicated to the use with EasyPGX ready kits.
Complete automated data analysis with a turnaround time < 5 min
No cloud or external data analysis solution
Totally automatic data analysis interpretation with the possibility to check raw data in one single software
Run and sample automatic QC
Automatic calculation of molecular response (MR) and International Scale (%IS)
Data export and report on different common formats
EasyPGX ready BCR-ABL Fusion code RT038 (48 test - CE IVD)
Qualitative detection and discrimination of principal BCR/ ABL fusion variants.*
EasyPGX ready PML-RARA Fusion code RT042 (48 test - CE IVD)
Qualitative detection and discrimination of principal PML/ RARA/ABL fusion variants.**
EasyPGX ready AML1-ETO Fusion code RT043 (48 test - CE IVD)
Qualitative detection of AML1-ETOt(8;21) fusion.
EasyPGX ready CBFB-MYH11 Fusion code RT044 (48 test - CE IVD)
Qualitative detection and discrimination of CBFB-MYH11 A, D and E fusions caused by inv(16)/t(16;16).**
EasyPGX ready IDH1-2 code RT031 (48 test - CE IVD)
EasyPGX ready IDH1-2 (code RT031 – 48 test, CE IVD) is a validated kit for in vitro diagnostic use for the qualitative detection by Real-Time PCR of the principal IDH1/2 mutations in genomic DNA isolated from blood, bone marrow or tumor tissue (FFPE).
Sensitivity up to 1% AF
From DNA to result in less than 2 hours with a hands-on time of less than 10 minutes, PCR run 90 minutes.